Pablo A. Silveira
Concord, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A Clinically Relevant Mouse Model of Reduced-Intensity Conditioning for Allogeneic HLA-Identical Hematopoietic Stem Cell Transplantation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 18, 2025
A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 18, 2024
Tropoelastin modulates systemic and local tissue responses to enhance wound healing.
Journal: Acta biomaterialia
Published: December 11, 2023
CD300f signalling induces inhibitory human monocytes/macrophages.
Journal: Cellular immunology
Published: December 18, 2022
Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis.
Journal: Frontiers in immunology
Published: September 28, 2021
Dihydrotestosterone (DHT) Enhances Wound Healing of Major Burn Injury by Accelerating Resolution of Inflammation in Mice.
Journal: International journal of molecular sciences
Published: July 27, 2020
Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?
Journal: Journal of clinical medicine
Published: January 31, 2020
Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody.
Journal: Clinical & translational immunology
Published: January 21, 2020
Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia.
Journal: Blood advances
Published: November 27, 2019
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.
Journal: Molecular oncology
Published: June 05, 2019
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential.
Journal: Frontiers in immunology
Published: March 14, 2019
Examination of CD302 as a potential therapeutic target for acute myeloid leukemia.
Journal: PloS one
Published: February 07, 2019
Last Updated: 09/26/2026